Europe - Frankfurt Stock Exchange - FRA:1AE - NL0010832176 - Common Stock
We assign a fundamental rating of 6 out of 10 to 1AE. 1AE was compared to 85 industry peers in the Biotechnology industry. While 1AE has a great health rating, its profitability is only average at the moment. 1AE is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make 1AE a good candidate for growth investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.84% | ||
| ROE | 21% | ||
| ROIC | 5.36% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.3% | ||
| PM (TTM) | 41.97% | ||
| GM | 89.4% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.14 | ||
| Altman-Z | 29.75 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.6 | ||
| Quick Ratio | 5.27 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 66.23 | ||
| Fwd PE | 27.47 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 165.09 | ||
| EV/EBITDA | 92.55 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 6 / 10 to 1AE.DE.
ChartMill assigns a valuation rating of 5 / 10 to ARGENX SE (1AE.DE). This can be considered as Fairly Valued.
ARGENX SE (1AE.DE) has a profitability rating of 5 / 10.
The financial health rating of ARGENX SE (1AE.DE) is 8 / 10.
The Earnings per Share (EPS) of ARGENX SE (1AE.DE) is expected to grow by 934.93% in the next year.